155 related articles for article (PubMed ID: 12358132)
1. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy.
Takano H; Zou Y; Akazawa H; Toko H; Mizukami M; Hasegawa H; Asakawa M; Nagai T; Komuro I
Hypertens Res; 2002 Jul; 25(4):491-8. PubMed ID: 12358132
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy.
Zou Y; Takano H; Akazawa H; Nagai T; Mizukami M; Komuro I
Endocr J; 2002 Feb; 49(1):1-13. PubMed ID: 12008744
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
4. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart.
Terrell AM; Crisostomo PR; Wairiuko GM; Wang M; Morrell ED; Meldrum DR
Shock; 2006 Sep; 26(3):226-34. PubMed ID: 16912647
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets and regulators of cardiac hypertrophy.
Rohini A; Agrawal N; Koyani CN; Singh R
Pharmacol Res; 2010 Apr; 61(4):269-80. PubMed ID: 19969085
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin and beyond: cardiac hypertrophic signaling.
Molkentin JD
Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.
Molkentin JD; Dorn GW
Annu Rev Physiol; 2001; 63():391-426. PubMed ID: 11181961
[TBL] [Abstract][Full Text] [Related]
8. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
9. Cardiac hypertrophy: sorting out the circuitry.
McKinsey TA; Olson EN
Curr Opin Genet Dev; 1999 Jun; 9(3):267-74. PubMed ID: 10377279
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular targets in the treatment of cardiac hypertrophy.
Luedde M; Katus HA; Frey N
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):1-20. PubMed ID: 18221071
[TBL] [Abstract][Full Text] [Related]
11. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways.
Ruwhof C; van der Laarse A
Cardiovasc Res; 2000 Jul; 47(1):23-37. PubMed ID: 10869527
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure.
Haq S; Choukroun G; Lim H; Tymitz KM; del Monte F; Gwathmey J; Grazette L; Michael A; Hajjar R; Force T; Molkentin JD
Circulation; 2001 Feb; 103(5):670-7. PubMed ID: 11156878
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
14. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.
Bueno OF; Molkentin JD
Circ Res; 2002 Nov; 91(9):776-81. PubMed ID: 12411391
[TBL] [Abstract][Full Text] [Related]
15. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
16. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
[TBL] [Abstract][Full Text] [Related]
17. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
Balakumar P; Jagadeesh G
Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
[TBL] [Abstract][Full Text] [Related]
19. [Intracellular signaling pathways for cardiac hypertrophy: ERK, JAK-STAT, S6 kinase].
Nobori K; Munehisa Y
Nihon Rinsho; 2007 Apr; 65 Suppl 4():196-200. PubMed ID: 17511075
[No Abstract] [Full Text] [Related]
20. Calcineurin and cardiac hypertrophy: where have we been? Where are we going?
Wilkins BJ; Molkentin JD
J Physiol; 2002 May; 541(Pt 1):1-8. PubMed ID: 12015416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
